GlassScriptPhysician profile
Tyrone L Mccall
NPI 1629006036
$2,922.73
in general payments reported to CMS, 2019-2025
18 companies · $527 in 2025
The $527 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $553 · 2020: $94.70 · 2021: $526 · 2022: $446 · 2023: $563 · 2024: $214 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $751.07 | 2019-2025 | Clareon Panoptix Pro, Clareon, Eysuvis |
| Glaukos Corporation | $661.85 | 2019-2023 | |
| Biotissue Holdings INC. | $369.00 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $220.25 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $184.09 | 2023-2025 | Miebo, Xiidra |
| Rxsight INC | $181.92 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Sun Pharmaceutical Industries INC. | $120.81 | 2019-2023 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $92.70 | 2021-2025 | Tecnis Iol, Idesign Rs |
| Harrow Eye, LLC | $86.60 | 2024-2025 | Vevye |
| Eyevance Pharmaceuticals LLC | $73.93 | 2019-2022 | |
| Shire North American Group INC | $51.27 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $22.51 | 2024 | Xdemvy |
| Rayner Intraocular Lenses Limited | $20.43 | 2023 | Rayone Emv, Omidria, Rayone Aspheric |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Dompe US, INC. | $18.86 | 2024 | Oxervate |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $17.80 | 2019 | |
| Halozyme INC | $15.82 | 2022 | |
| Oyster Point Pharma, INC. | $14.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyrone Mccall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.